Evidence map›Paper›PMID 39250423›Full record

ArticleeLife2024

Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapy.

Lesia Semenova, Yingfan Wang, Shane Falcinelli, Nancie Archin, Alicia D Cooper-Volkheimer, David M Margolis, Nilu Goonetilleke, David M Murdoch, Cynthia D Rudin, Edward P Browne

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Lesia SemenovaMicrosoft Research, Duke University, Durham, United States.
Yingfan WangDepartment of Computer Science, Duke University, Durham, United States.
Shane FalcinelliUNC HIV Cure Center UNC Chapel Hill, Chapel Hill, United States.
Nancie ArchinUNC HIV Cure Center UNC Chapel Hill, Chapel Hill, United States.
Alicia D Cooper-VolkheimerDepartment of Medicine, Duke University, Durham, United States.
David M MargolisUNC HIV Cure Center UNC Chapel Hill, Chapel Hill, United States.
Nilu GoonetillekeUNC HIV Cure Center UNC Chapel Hill, Chapel Hill, United States.ORCID https://orcid.org/0000-0003-2278-1656
David M MurdochDepartment of Medicine, Duke University, Durham, United States.ORCID https://orcid.org/0000-0001-7201-7950
Cynthia D RudinDepartment of Computer Science, Duke University, Durham, United States.
Edward P BrowneUNC HIV Cure Center UNC Chapel Hill, Chapel Hill, United States.ORCID https://orcid.org/0000-0001-9070-7015

Funding

Collaboratory of AIDS Researchers for Eradication (CARE)UM1AI164567 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2021 to 2026
$31.6M
POLYCOMB REPRESSIVE COMLEXE AS KEY REGULATORS OF HIV LATENCY AND TARGETS FOR LATENCY REVERSALR61DA047023 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JAMES, LINDSEY INGERMAN · 2018 to 2020
$2.7M
A machine learning framework for understanding impacts on the HIV latent reservoir size, including drugs of abuseR01DA054994 · NIDA · DUKE UNIVERSITY · PI RUDIN, CYNTHIA · 2021 to 2025
$2.3M
Defining the impact of cannabinoids on the latent HIV reservoir through multi-omic analysisR61DA053599 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BROWNE, EDWARD P · 2021 to 2023
$2.0M
Regulation of HIV Latency by Host Cell Transcriptional and Epigenetic NetworksR01AI143381 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BROWNE, EDWARD P · 2019 to 2022
$1.6M
Reducing the HIV Reservoir: Next-Generation Latency Reversal Agents and T Cell Population TargetsF30AI145588 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FALCINELLI, SHANE DAVID · 2019 to 2023
$217k
NIAID NIH HHS F30 AI145588NIAID NIH HHS R01 AI143381NIAID NIH HHS UM1 AI164567NIDA NIH HHS R01 DA054994NIDA NIH HHS R61 DA047023NIDA NIH HHS R61 DA053599
6 · The paper itself

Abstract

Understanding the interplay between the HIV reservoir and the host immune system may yield insights into HIV persistence during antiretroviral therapy (ART) and inform strategies for a cure. Here, we applied machine learning (ML) approaches to cross-sectional high-parameter HIV reservoir and immunology data in order to characterize host-reservoir associations and generate new hypotheses about HIV reservoir biology. High-dimensional immunophenotyping, quantification of HIV-specific T cell responses, and measurement of genetically intact and total HIV proviral DNA frequencies were performed on peripheral blood samples from 115 people with HIV (PWH) on long-term ART. Analysis demonstrated that both intact and total proviral DNA frequencies were positively correlated with T cell activation and exhaustion. Years of ART and select bifunctional HIV-specific CD4 T cell responses were negatively correlated with the percentage of intact proviruses. A leave-one-covariate-out inference approach identified specific HIV reservoir and clinical-demographic parameters, such as age and biological sex, that were particularly important in predicting immunophenotypes. Overall, immune parameters were more strongly associated with total HIV proviral frequencies than intact proviral frequencies. Uniquely, however, expression of the IL-7 receptor alpha chain (CD127) on CD4 T cells was more strongly correlated with the intact reservoir. Unsupervised dimension reduction analysis identified two main clusters of PWH with distinct immune and reservoir characteristics. Using reservoir correlates identified in these initial analyses, decision tree methods were employed to visualize relationships among multiple immune and clinical-demographic parameters and the HIV reservoir. Finally, using random splits of our data as training-test sets, ML algorithms predicted with approximately 70% accuracy whether a given participant had qualitatively high or low levels of total or intact HIV DNA . The techniques described here may be useful for assessing global patterns within the increasingly high-dimensional data used in HIV reservoir and other studies of complex biology.

Indexed as

DNA, ViralHIV InfectionsMachine LearningAdultAnti-Retroviral AgentsCD4-Positive T-LymphocytesCross-Sectional StudiesFemaleHIV-1HumansMaleMiddle AgedProvirusesAnti-Retroviral AgentsDNA, ViralHIVhumanimmune cellsinfectious diseasemachine learningmicrobiology

Identifiers

PMID39250423
PMCPMC11383529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.